Enliven Therapeutics, Inc.
ELVN
$18.27
-$1.42-7.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.40% | -6.58% | -2.53% | 26.61% | -3.92% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -9.32% | -10.10% | -14.43% | 125.19% | -42.49% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | -99.46% | 0.00% | -- |
| Total Current Assets | 7.11% | -6.64% | -5.66% | 26.69% | -0.91% |
|
|
|||||
| Total Current Assets | 7.11% | -6.64% | -5.66% | 26.69% | -0.91% |
| Net Property, Plant & Equipment | -27.30% | -20.35% | -14.39% | -12.99% | -11.79% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.05% | -3.96% | 74.58% | 0.00% | 10.00% |
| Total Assets | 6.66% | -6.61% | -4.59% | 26.08% | -0.79% |
|
|
|||||
| Total Accounts Payable | 31.70% | -5.91% | -60.29% | 412.59% | -64.37% |
| Total Accrued Expenses | -8.52% | 38.24% | -2.10% | -20.85% | 48.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -49.70% | -32.94% | -24.78% | 0.90% |
| Total Finance Division Other Current Liabilities | -5.56% | -97.72% | -9.14% | 0.79% | 2,716.30% |
| Total Other Current Liabilities | -5.56% | -97.72% | -9.14% | 0.79% | 2,716.30% |
| Total Current Liabilities | -6.53% | -22.97% | -11.69% | -3.33% | 114.37% |
|
|
|||||
| Total Current Liabilities | -6.53% | -22.97% | -11.69% | -3.33% | 114.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -82.35% | -49.25% | -68.69% |
| Total Liabilities | -6.53% | -22.99% | -11.79% | -3.45% | 111.19% |
|
|
|||||
| Common Stock & APIC | 8.81% | 1.24% | 1.47% | 23.67% | 0.82% |
| Retained Earnings | -10.52% | -11.75% | -11.26% | -14.72% | -14.34% |
| Treasury Stock & Other | -77.27% | 274.10% | -162.26% | -137.59% | 195.92% |
| Total Common Equity | 7.43% | -5.42% | -4.02% | 29.20% | -6.05% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.43% | -5.42% | -4.02% | 29.20% | -6.05% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.43% | -5.42% | -4.02% | 29.20% | -6.05% |
|
|
|||||